help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MARQUES, L. J.
Right arrow Articles by COSTABEL, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MARQUES, L. J.
Right arrow Articles by COSTABEL, U.

Am. J. Respir. Crit. Care Med., Volume 156, Number 5, November 1997, 1700-1702

Smoker's Lung Transplanted to a Nonsmoker
Long-term Detection of Smoker's Macrophages

LEILA JOHN MARQUES, HELMUT TESCHLER, JOSUNE GUZMAN, and ULRICH COSTABEL

Department of Pneumology and Allergy, Ruhrlandklinik, Medical Faculty, University of Essen, Essen; General and Experimental Pathology, Ruhr University, Bochum, Germany

Alveolar macrophages (AM) from smokers contain characteristic smoker's inclusion bodies within the cytoplasm as a result of ingestion of substances in the inhaled smoke. How long these smoking-related changes in the AM population can be seen after smoking cessation is largely unknown. We had the unique opportunity to investigate a 51-yr-old never-smoker after single lung transplantation (TX) for alpha 1-antitrypsin deficiency emphysema who received a donor's lung from a heavy cigarette smoker. Serial bronchoalveolar lavage (BAL) was performed in the donor's lung for transplant surveillance at defined time intervals, and the percentage of AM with characteristic smoker's inclusions was counted on slides stained with May-Grünwald-Giemsa stain. The patient had an uneventful course after TX with no major infectious complications or episodes of rejection. One month after TX the percentage of smoker's AM was 98%. BAL after 2, 5, 7, and 12 mo showed a similar high percentage. After 18 mo a first a decrease was seen, down to 78%, and after 2 yr a decrease to 59% was seen. After 3 yr, the smoker's AM had mostly disappeared, only 3% were still present. In conclusion, smoker's inclusions in AM may be detected for at least 2 yr after smoking has ceased, which is considerably longer than the estimated life span of the AM.




This article has been cited by other articles:


Home page
 Am. J. Respir. Cell Mol. Bio.Home page
G. J. Gaschler, C. C. J. Zavitz, C. M. T. Bauer, M. Skrtic, M. Lindahl, C. S. Robbins, B. Chen, and M. R. Stampfli
Cigarette Smoke Exposure Attenuates Cytokine Production by Mouse Alveolar Macrophages
Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 218 - 226.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
J.-i. Machiya, Y. Shibata, K. Yamauchi, N. Hirama, T. Wada, S. Inoue, S. Abe, N. Takabatake, M. Sata, and I. Kubota
Enhanced Expression of MafB Inhibits Macrophage Apoptosis Induced by Cigarette Smoke Exposure
Am. J. Respir. Cell Mol. Biol., April 1, 2007; 36(4): 418 - 426.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. E. Girod and T. E. King Jr.
COPD: A Dust-Induced Disease?
Chest, October 1, 2005; 128(4): 3055 - 3064.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Nyunoya, M. M. Monick, L. S. Powers, T. O. Yarovinsky, and G. W. Hunninghake
Macrophages Survive Hyperoxia via Prolonged ERK Activation Due to Phosphatase Down-regulation
J. Biol. Chem., July 15, 2005; 280(28): 26295 - 26302.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
R.O. Crapo, R.L. Jensen, and F.E. Hargreave
Airway inflammation in COPD: physiological outcome measures and induced sputum
Eur. Respir. J., June 1, 2003; 21(41_suppl): 19S - 28s.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. Tomita, G. Caramori, S. Lim, K. Ito, T. Hanazawa, T. Oates, I. Chiselita, E. Jazrawi, K. F. Chung, P. J. Barnes, et al.
Increased p21CIP1/WAF1 and B Cell Lymphoma Leukemia-xL Expression and Reduced Apoptosis in Alveolar Macrophages from Smokers
Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 724 - 731.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias . This Joint Statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS Board of Directors, June 2001 and by The ERS Executive Committee, June 2001
Am. J. Respir. Crit. Care Med., January 15, 2002; 165(2): 277 - 304.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. Komuro, N. Keicho, A. Iwamoto, and K. S. Akagawa
Human Alveolar Macrophages and Granulocyte-macrophage Colony-stimulating Factor-induced Monocyte-derived Macrophages Are Resistant to H2O2 via Their High Basal and Inducible Levels of Catalase Activity
J. Biol. Chem., June 22, 2001; 276(26): 24360 - 24364.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1997 American Thoracic Society 		  Red In Translatin